tirzepatide and breast cancer For years, researchers have known that obesity is associated with an increased risk of developing dying from several cancers, including cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists tirzepatide breast cancer study GLP-1

Cover Image Credit: Feedough / 123RF.com (Licensed)

- B quyt ca ln da sn chc, n hi, lun ti tr, trn y sc sng

Les analogues du GLP-1 entranent frquemment des troubles digestifs (nauses, vomissements, diarrhe, constipation) chez environ 73 % des patients sous Wegovy

Ozempic and Wegovy are GLP-1RA diabetes and obesity treatments that are now being studied for a wide range of other positive health effects, including Parkinsons disease, Alzheimers, depression, anxiety, sleep apnea, and more

Clinical studies suggest that tirzepatide may produce greater average weight loss than semaglutide

We've worked with specialists to ensure the assessment provides sufficient clinical context for the healthcare provider to make an informed prescribing decision